REG - Nat Bank of Canada - Publication of a Supplementary Prospectus

National Bank of CanadaAnnouncement

05/12/2025 13:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251205:nRSE4872Ka&default-theme=true

RNS Number : 4872K  National Bank of Canada  05 December 2025

Regulatory Announcement

 

RNS Number: 4872K

National Bank of Canada

5 December 2025

 

Publication of Prospectus

 

The following supplement constitutes supplementary admission particulars for
purposes of the International Securities Market Rulebook and is available for
viewing:

 

The 2(nd) prospectus supplement dated 5 December 2025 (the "2(nd) Supplement")
relating to the U.S.$25,000,000,000 Note Issuance Programme of National Bank
of Canada.

 

The 2(nd) Supplement and the document incorporated by reference therein have
been submitted to the National Storage Mechanism and will shortly be available
for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism) .

 

DISCLAIMER - INTENDED ADDRESSEES

 

Please note that the information contained in the prospectus dated 13 June
2025, as supplemented by the 1(st) Supplement dated 27 August 2025 and the
2(nd) Supplement dated 5 December 2025  (together, the "Prospectus") may be
addressed to and/or targeted at persons who are residents of particular
countries (specified in the Prospectus) only and is not intended for use and
should not be relied upon by any person outside these countries and/or to whom
the offer contained in the Prospectus is not addressed. Prior to relying on
the information contained in the Prospectus you must ascertain from the
Prospectus whether or not you are part of the intended addressees of the
information contained therein.

 

The Notes have not been and will not be registered under the United States
Securities Act of 1933, as amended (the "Securities Act") or the securities
laws of any state of the United States and are subject to United States tax
law requirements. Subject to certain exceptions, the Notes may not be offered,
sold or delivered, directly or indirectly, in the United States or to or for
the account of a "U.S. person" (as defined in Regulation S under the
Securities Act).  No public offering of the Notes is being made in the United
States. This announcement does not constitute an offer to sell or a
solicitation to buy securities in the United States or in any other
jurisdiction where such offer or solicitation would be unlawful.

 

Your right to access this service is conditional upon complying with the above
requirements.

 

To view the full Prospectus and the document incorporated by reference
therein, please paste the following URLs into the address bar of your browser:

 

2(nd) Supplement dated 5 December 2025

http://www.rns-pdf.londonstockexchange.com/rns/4872K_1-2025-12-5.pdf
(http://www.rns-pdf.londonstockexchange.com/rns/4872K_1-2025-12-5.pdf)

 

Documents partially or entirely incorporated by reference in the Prospectus:

 

2025 Annual Report

http://www.rns-pdf.londonstockexchange.com/rns/4872K_3-2025-12-5.pdf
(http://www.rns-pdf.londonstockexchange.com/rns/4872K_3-2025-12-5.pdf)

 

2025 Annual Information Form

http://www.rns-pdf.londonstockexchange.com/rns/4872K_2-2025-12-5.pdf
(http://www.rns-pdf.londonstockexchange.com/rns/4872K_2-2025-12-5.pdf)

 

 

For further information, please contact:

 

Jean-Philippe Drolet

Managing Director and Head of Funding

National Bank of Canada

 

Phone: + 1 (514) 394 8242

Email: jeanphilippe.drolet@bnc.ca

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  PSPEAFASESDSFFA



            Copyright 2019 Regulatory News Service, all rights reserved